0001968202-24-000064.txt : 20240213
0001968202-24-000064.hdr.sgml : 20240213
20240213160428
ACCESSION NUMBER: 0001968202-24-000064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240209
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Plew Daniel P
CENTRAL INDEX KEY: 0001411984
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 24625615
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-02-09
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001411984
Van Plew Daniel P
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP & General Mgr, Industrial
0
Common Stock
2024-02-09
4
M
0
12250
372.46
A
32628
D
Common Stock
2024-02-09
4
F
0
8600
951.68
D
24028
D
Common Stock
2024-02-09
4
M
0
23125
381.4
A
47153
D
Common Stock
2024-02-09
4
F
0
16341
951.68
D
30812
D
Common Stock
12376
I
2023 GRAT
Common Stock
1084
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
372.46
2024-02-09
4
M
0
12250
0.0
D
2029-12-11
Common Stock
12250
12250
D
Non-Qualified Stock Option (right to buy)
381.4
2024-02-09
4
M
0
23125
0.0
D
2028-12-12
Common Stock
23125
0
D
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**Daniel P. Van Plew
2024-02-13